Income Statement (TTM)
Medigene AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 8 | 8 | 9 | 10 | 10 | 21 | 31 | 31 | 31 | 20 | 9 | 8 | 6 | 7 | 7 |
| Change (%) | -15.17 | 3.86 | 3.72 | 10.69 | 9.66 | 100.32 | 50.08 | -0.33 | -0.33 | -35.56 | -55.17 | -16.58 | -19.87 | 11.70 | 10.47 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Change (%) | 100.00 | 24.50 | 19.68 | -14.68 | -17.20 | 6.69 | 6.27 | 14.30 | 12.51 | 2.70 | 2.63 | -10.69 | -11.97 | -4.53 | -4.75 | |
| % of Revenue | 6.85 | 16.15 | 19.35 | 22.33 | 17.21 | 13.00 | 6.92 | 4.90 | 5.62 | 6.35 | 10.11 | 23.15 | 24.79 | 27.23 | 23.27 | 20.06 |
| Gross Operating Profit | 9 | 7 | 7 | 7 | 8 | 9 | 20 | 30 | 30 | 29 | 18 | 7 | 6 | 4 | 5 | 6 |
| Change (%) | -23.63 | -0.11 | -0.11 | 17.98 | 15.24 | 114.31 | 53.34 | -1.09 | -1.10 | -38.15 | -61.68 | -18.35 | -22.48 | 17.77 | 15.09 | |
| % of Revenue | 93.15 | 83.85 | 80.65 | 77.67 | 82.79 | 87.00 | 93.08 | 95.10 | 94.38 | 93.65 | 89.89 | 76.85 | 75.21 | 72.77 | 76.73 | 79.94 |
| SG&A | 9 | 9 | 8 | 7 | 7 | 7 | 8 | 10 | 10 | 10 | 9 | 8 | 9 | 9 | 9 | 9 |
| Change (%) | 0.36 | -8.95 | -9.82 | -1.34 | -1.36 | 23.05 | 18.74 | -0.53 | -0.53 | -9.34 | -10.31 | 8.07 | 7.47 | -1.48 | -1.51 | |
| % of Revenue | 90.39 | 106.94 | 93.75 | 81.51 | 72.65 | 65.35 | 40.15 | 31.76 | 31.70 | 31.64 | 44.50 | 89.04 | 115.36 | 154.72 | 136.46 | 121.66 |
| R&D | 23 | 22 | 20 | 17 | 14 | 11 | 10 | 9 | 8 | 8 | 9 | 10 | 11 | 12 | 12 | 13 |
| Change (%) | -3.74 | -12.04 | -13.68 | -16.67 | -20.01 | -11.80 | -13.37 | -2.96 | -3.05 | 9.45 | 8.63 | 9.95 | 9.05 | 4.76 | 4.55 | |
| % of Revenue | 245.19 | 278.21 | 235.62 | 196.09 | 147.62 | 107.68 | 47.42 | 27.37 | 26.65 | 25.92 | 44.02 | 106.67 | 140.59 | 191.33 | 179.45 | 169.82 |
| OpEx | 34 | 35 | 32 | 29 | 24 | 19 | 19 | 20 | 20 | 20 | 19 | 19 | 21 | 22 | 23 | 23 |
| Change (%) | 4.30 | -9.13 | -10.05 | -17.36 | -21.01 | 2.16 | 2.12 | -0.13 | -0.13 | -0.47 | -0.48 | 7.30 | 6.81 | 1.53 | 1.51 | |
| % of Revenue | 357.78 | 439.87 | 384.85 | 333.78 | 249.19 | 179.50 | 91.54 | 62.29 | 62.41 | 62.54 | 96.58 | 214.42 | 275.81 | 367.63 | 334.16 | 307.04 |
| Operating Income | -24 | -27 | -24 | -20 | -14 | -8 | 2 | 12 | 12 | 12 | 1 | -10 | -13 | -16 | -16 | -15 |
| Change (%) | 11.85 | -12.95 | -14.88 | -29.36 | -41.57 | -121.31 | 569.28 | -0.66 | -0.67 | -94.12 | -1,600.22 | 28.17 | 21.98 | -2.27 | -2.32 | |
| % of Revenue | -257.78 | -339.87 | -284.85 | -233.78 | -149.19 | -79.50 | 8.46 | 37.71 | 37.59 | 37.46 | 3.42 | -114.42 | -175.81 | -267.63 | -234.16 | -207.04 |
| Interest Expense | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -0 | -1 | -1 | -1 | -1 |
| Change (%) | -42.80 | -4.14 | -4.31 | -3.01 | -3.10 | -4.51 | -4.72 | 51.28 | 33.90 | -11.28 | -12.71 | 5.40 | 5.12 | -0.00 | -0.00 | |
| % of Revenue | -7.39 | -4.99 | -4.60 | -4.25 | -3.72 | -3.29 | -1.57 | -1.00 | -1.51 | -2.03 | -2.79 | -5.44 | -6.87 | -9.02 | -8.07 | -7.31 |
| Net Income | -25 | -29 | -25 | -22 | -16 | -10 | -0 | 10 | 1 | -8 | -19 | -29 | -23 | -16 | -16 | -16 |
| Change (%) | 13.89 | -11.89 | -13.50 | -27.32 | -37.58 | -98.09 | -5,126.70 | -93.38 | -1,410.78 | 125.38 | 55.63 | -22.32 | -28.73 | -0.75 | -0.76 | |
| % of Revenue | -268.78 | -360.85 | -306.11 | -255.29 | -167.63 | -95.41 | -0.91 | 30.52 | 2.03 | -26.66 | -93.23 | -323.68 | -301.41 | -268.10 | -238.20 | -213.98 |
Source: Capital IQ
